Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 54
- Registration Number
- NCT03871959
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue
- Conditions
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 80
- Registration Number
- NCT03841799
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
🇫🇷GARBIT Vincent, Lyon, France
Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
- Conditions
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 33
- Registration Number
- NCT03818061
- Locations
- 🇫🇷
Centre Henri Becquerel, Rouen, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease
- Conditions
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 95
- Registration Number
- NCT03818685
- Locations
- 🇫🇷
Hopital Prive Jean Mermoz, Lyon, France
🇫🇷Centre Antoine Lacassagne, Nice, France
🇫🇷Clinique de la Sauvegarde, Lyon, France
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 35
- Registration Number
- NCT03732495
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷CHU Angers, Angers, France
🇫🇷CHU Bordeaux - Hôpital Saint-André, Bordeaux, France
FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel
- Conditions
- Interventions
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 104
- Registration Number
- NCT03723967
- Locations
- 🇫🇷
Centre Henri Becquerel, Rouen, France
🇫🇷Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy, France
🇫🇷Clinique des Ormeaux, Le Havre, France
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 319
- Registration Number
- NCT03721120
- Locations
- 🇫🇷
Centre Maurice Tubiana, Caen, France
🇫🇷Infirmerie Protestante, Caluire et Cuire, France
🇫🇷Hopital Louis Pradel, Bron, France
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type
- Conditions
- Interventions
- First Posted Date
- 2018-10-22
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 12
- Registration Number
- NCT03714958
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)
- Conditions
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 30
- Registration Number
- NCT03628859
- Locations
- 🇫🇷
Centre Leon Berard, Lyon, France
Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)
- Conditions
- Interventions
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Centre Leon Berard
- Target Recruit Count
- 40
- Registration Number
- NCT03624244
- Locations
- 🇫🇷
CHU Tours, Tours, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷Insitut Bergonié, Bordeaux, France